News and Trends 7 Dec 2017
Scottish Biotech and Bluebird Bio to Develop Next Generation CAR-T Cells
TC Biopharm has scored a deal with bluebird bio for the development of the next generation of CAR-T cells, a technology giving new hope to cancer patients. With the first two CAR-T therapies now in the market, the way we treat cancer is changing. This technology has shown to be effective in a high percentage of patients […]